Role of NADPH Quinone Reductase 1 (NQO1) Polymorphism in Prevention, Diagnosis, and Treatment of Gastrointestinal Cancers.

doi:10.2174/0115680096283149240109094710

Back to search

Article

Role of NADPH Quinone Reductase 1 (NQO1) Polymorphism in Prevention, Diagnosis, and Treatment of Gastrointestinal Cancers.

Current cancer drug targets - 1 Jan 2024

Ghorbani Fereshte, Mazidimoradi Afrooz, Biyabani Arezou, Allahqoli Leila, Salehiniya Hamid

Abstract excerpt

Most cancer deaths are related to gastrointestinal (GI) cancers. Several environmental and genetic factors are effective in the occurrence of GI cancers, such as esophageal, stomach, colorectal, liver, and pancreatic cancers. In addition to risk factors related to lifestyle, reactive oxygen speci...

Topics

NAD(P)H Dehydrogenase (Quinone)
Humans
Gastrointestinal Neoplasms
Polymorphism, Single Nucleotide
Biomarkers, Tumor
Genetic Predisposition to Disease

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.